digital biomarkers

The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.

Medidata said the deal will help better integrate clinical-grade metrics into its remote trial platform and broadly support the use of wearable sensors for clinical research.

The latest round brings the company's funding total to $160 million. 

In this grab-bag episode of HIMSSCast, Laura Lovett, an editor at MobiHealthNews, chats with host Jonah Comstock about three recent in-person reporting experiences here in the Boston area, where MobiHealthNews is based.